Growth Metrics

Tvardi Therapeutics (TVRD) Other Working Capital Changes (2016 - 2025)

Tvardi Therapeutics' Other Working Capital Changes history spans 13 years, with the latest figure at $383000.0 for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 132.1% to $383000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $308000.0, a 95.3% decrease, with the full-year FY2025 number at $308000.0, up 4.23% from a year prior.
  • Other Working Capital Changes hit $383000.0 in Q4 2025 for Tvardi Therapeutics, up from -$26000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for TVRD hit a ceiling of $15.0 million in Q4 2022 and a floor of -$6.8 million in Q4 2023.
  • Historically, Other Working Capital Changes has averaged $772491.3 across 5 years, with a median of $235827.5 in 2022.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 2911.91% in 2021 and later surged 83053.85% in 2022.
  • Tracing TVRD's Other Working Capital Changes over 5 years: stood at $4.2 million in 2021, then skyrocketed by 256.93% to $15.0 million in 2022, then crashed by 145.42% to -$6.8 million in 2023, then soared by 82.55% to -$1.2 million in 2024, then skyrocketed by 132.1% to $383000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for TVRD at $383000.0 in Q4 2025, -$26000.0 in Q3 2025, and -$1.1 million in Q2 2025.